Hypercalcemia in Children Following a Discontinuation of Denosumab Therapy: A Case Report and Literature Review
Clinical Pediatrics · 2024
DOI: 10.1177/00099228231194427 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Pediatrics, 2024. Verfasst von Xu Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, China. Hauptthemen laut MEDLINE: Denosumab, Hypercalcemia, Bone Density Conservation Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Guangxi Clinical Research Center of Pediatric Diseases, Scientific research Foundation of the First Affiliated Hospital of Guangxi Medical University.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
ORCID-Profile: Xu Liu
Förderung
- Guangxi Clinical Research Center of Pediatric Diseases
- Scientific research Foundation of the First Affiliated Hospital of Guangxi Medical University
Zitieren
APA
Liu, X., Xie, Y., Tang, J., Zhong, J., & Lan, D. (2024). Hypercalcemia in Children Following a Discontinuation of Denosumab Therapy: A Case Report and Literature Review. Clinical Pediatrics. https://doi.org/10.1177/00099228231194427
Vancouver
Liu X, Xie Y, Tang J, Zhong J, Lan D. Hypercalcemia in Children Following a Discontinuation of Denosumab Therapy: A Case Report and Literature Review. Clinical Pediatrics. 2024. doi:10.1177/00099228231194427
BibTeX
@article{Liu2024,
author = {Liu, Xu and Xie, Yanshu and Tang, Jing and Zhong, Jingzi and Lan, Dan},
title = {Hypercalcemia in Children Following a Discontinuation of Denosumab Therapy: A Case Report and Literature Review},
journal = {Clinical Pediatrics},
year = {2024},
doi = {10.1177/00099228231194427}
}
EUVIMED